P67 The SLE-DAS enables easy identification of SLE patients with severe disease activity and worse health-related quality of life: derivation and validation in post-hoc study of anifrolumab phase 2 and 3 clinical trials
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-03-01
|
| Series: | Lupus Science and Medicine |
| _version_ | 1797260094636818432 |
|---|---|
| author | Andrea Doria Diogo Jesus Ana Matos Carla Henriques Luís Sousa Inês |
| author_facet | Andrea Doria Diogo Jesus Ana Matos Carla Henriques Luís Sousa Inês |
| author_sort | Andrea Doria |
| collection | DOAJ |
| first_indexed | 2024-04-24T23:19:52Z |
| format | Article |
| id | doaj.art-b50e99206cfd4047aebe7362ed1b2404 |
| institution | Directory Open Access Journal |
| issn | 2053-8790 |
| language | English |
| last_indexed | 2024-04-24T23:19:52Z |
| publishDate | 2024-03-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Lupus Science and Medicine |
| spelling | doaj.art-b50e99206cfd4047aebe7362ed1b24042024-03-16T16:10:08ZengBMJ Publishing GroupLupus Science and Medicine2053-87902024-03-0111Suppl 110.1136/lupus-2024-el.121P67 The SLE-DAS enables easy identification of SLE patients with severe disease activity and worse health-related quality of life: derivation and validation in post-hoc study of anifrolumab phase 2 and 3 clinical trialsAndrea Doria0Diogo Jesus1Ana Matos2Carla Henriques3Luís Sousa Inês41Department of Medicine, University of Padua, ItalyRheumatology Department, Leiria Hospital Centre, Pousos, Portugal5Research Centre in Digital Services (CISeD), Viseu, Portugal3School of Technology and Management, Polytechnic Institute of Viseu, Viseu, Portugal7CHUC Lupus Clinic, Rheumatology Dept., Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal |
| spellingShingle | Andrea Doria Diogo Jesus Ana Matos Carla Henriques Luís Sousa Inês P67 The SLE-DAS enables easy identification of SLE patients with severe disease activity and worse health-related quality of life: derivation and validation in post-hoc study of anifrolumab phase 2 and 3 clinical trials Lupus Science and Medicine |
| title | P67 The SLE-DAS enables easy identification of SLE patients with severe disease activity and worse health-related quality of life: derivation and validation in post-hoc study of anifrolumab phase 2 and 3 clinical trials |
| title_full | P67 The SLE-DAS enables easy identification of SLE patients with severe disease activity and worse health-related quality of life: derivation and validation in post-hoc study of anifrolumab phase 2 and 3 clinical trials |
| title_fullStr | P67 The SLE-DAS enables easy identification of SLE patients with severe disease activity and worse health-related quality of life: derivation and validation in post-hoc study of anifrolumab phase 2 and 3 clinical trials |
| title_full_unstemmed | P67 The SLE-DAS enables easy identification of SLE patients with severe disease activity and worse health-related quality of life: derivation and validation in post-hoc study of anifrolumab phase 2 and 3 clinical trials |
| title_short | P67 The SLE-DAS enables easy identification of SLE patients with severe disease activity and worse health-related quality of life: derivation and validation in post-hoc study of anifrolumab phase 2 and 3 clinical trials |
| title_sort | p67 the sle das enables easy identification of sle patients with severe disease activity and worse health related quality of life derivation and validation in post hoc study of anifrolumab phase 2 and 3 clinical trials |
| work_keys_str_mv | AT andreadoria p67thesledasenableseasyidentificationofslepatientswithseverediseaseactivityandworsehealthrelatedqualityoflifederivationandvalidationinposthocstudyofanifrolumabphase2and3clinicaltrials AT diogojesus p67thesledasenableseasyidentificationofslepatientswithseverediseaseactivityandworsehealthrelatedqualityoflifederivationandvalidationinposthocstudyofanifrolumabphase2and3clinicaltrials AT anamatos p67thesledasenableseasyidentificationofslepatientswithseverediseaseactivityandworsehealthrelatedqualityoflifederivationandvalidationinposthocstudyofanifrolumabphase2and3clinicaltrials AT carlahenriques p67thesledasenableseasyidentificationofslepatientswithseverediseaseactivityandworsehealthrelatedqualityoflifederivationandvalidationinposthocstudyofanifrolumabphase2and3clinicaltrials AT luissousaines p67thesledasenableseasyidentificationofslepatientswithseverediseaseactivityandworsehealthrelatedqualityoflifederivationandvalidationinposthocstudyofanifrolumabphase2and3clinicaltrials |